RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group

Sini Luoma, Pekka Anttila, Marjaana Säily, Tuija Lundan, Jouni Heiskanen, Timo Siitonen, Sakari Kakko, Mervi Putkonen, Hanna Ollikainen, Venla Terävä, Marja Sankelo, Anu Partanen, Kirsi Launonen, Anu Räsänen, Anu Sikiö, Merja Suominen, Piotr Bazia, Kristiina Kananen, Juha Lievonen, Tuomas SelanderTarja-Terttu Pelliniemi, Sorella Ilveskero, Virva Huotari, Pentti Mäntymaa, Anri Tienhaara, Esa Jantunen, Raija Silvennoinen

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalAnnals of Hematology
Volume98
Issue number12
Pages (from-to)2781-2792
Number of pages12
ISSN0939-5555
DOIs
Publication statusPublished - Dec 2019
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Multiple myeloma
  • Flow cytometry
  • PCR
  • Minimal residual disease
  • Lenalidomide
  • Maintenance
  • MINIMAL RESIDUAL DISEASE
  • MOLECULAR REMISSION
  • DEXAMETHASONE
  • BORTEZOMIB
  • CYCLOPHOSPHAMIDE
  • MOBILIZATION
  • GUIDELINES
  • CRITERIA
  • OUTCOMES
  • FLOW
  • 3121 General medicine, internal medicine and other clinical medicine

Cite this